Showing results (61-70 of 289) with videos related to
Sort By:
Pageof 29
Molecular Neurodegeneration|July 28, 2009
Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neuronsJoão Paulo L Daher, Mingyao Ying, Rebecca Banerjee, et al.Experimental Neurology|December 4, 2002
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's diseaseStefan Lorenzl, David S Albers, Sabine Narr, et al.Experimental Neurology|January 15, 2005
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosisMahmoud Kiaei, Khatuna Kipiani, Junyu Chen, et al.Journal of the Neurological Sciences|October 20, 2006
Loss of Fas ligand-function improves survival in G93A-transgenic ALS miceSusanne Petri, Mahmoud Kiaei, Elizabeth Wille, et al.Journal of Neurochemistry|January 15, 2004
Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosisPeter Klivenyi, Mahmoud Kiaei, Gabrielle Gardian, et al.Journal of Molecular Neuroscience : MN|December 4, 2003
Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's diseasePeter Klivenyi, Gabrielle Gardian, Noel Y Calingasan, et al.Antioxidants & Redox Signaling|July 24, 2009
Parkinson's disease: from molecular pathways in disease to therapeutic approachesBobby ThomasHuman Molecular Genetics|March 26, 2015
Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tauFadi Mikhail, Noel Calingasan, Luca Parolari, et al.BMC Neuroscience|September 3, 2009
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's diseaseKatharina Faust, Stephan Gehrke, Yufeng Yang, et al.Experimental Neurology|June 22, 2010
Resveratrol protects against peripheral deficits in a mouse model of Huntington's diseaseDaniel J Ho, Noel Y Calingasan, Elizabeth Wille, et al.Pageof 29